159 related articles for article (PubMed ID: 9422088)
21. Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen.
Schuman JT; Grinstead JS; Apostolopoulos V; Campbell AP
Biopolymers; 2005 Feb; 77(2):107-20. PubMed ID: 15635690
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Pepscan analyses for epitope mapping of anti-MUC1 monoclonal antibodies--a comparative study and review of five antibodies.
Petrakou E; Murray A; Rosamund C; Graves L; Price MR
Anticancer Res; 1998; 18(6A):4419-21. PubMed ID: 9891503
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical characterization of a panel of 56 antibodies with normal human small intestine, colon, and breast tissues.
Cao Y; Karsten U; Hilgers J
Tumour Biol; 1998; 19 Suppl 1():88-99. PubMed ID: 9422093
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the role of type 1 core O-glycans in the binding of anti-MUC1 antibodies by cytofluorometry and synthetic peptide/glycopeptide binding inhibition studies.
Reddish MA; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker BM
Tumour Biol; 1998; 19 Suppl 1():57-66. PubMed ID: 9422089
[TBL] [Abstract][Full Text] [Related]
25. Determination of carbohydrate specificity of monoclonal antibodies against MUC1.
Galanina OE; Simeoni LA; Ter-Grigoryan AG; Belyanchikov IM; Bovin NV
Tumour Biol; 1998; 19 Suppl 1():79-87. PubMed ID: 9422092
[TBL] [Abstract][Full Text] [Related]
26. Epitope-dependent differential immunoreactivities of anti-MUC1 monoclonal antibodies in human carcinomas.
Baldus SE; Goergen D; Hanisch FG; Dienes HP
Int J Oncol; 2001 Mar; 18(3):507-12. PubMed ID: 11179479
[TBL] [Abstract][Full Text] [Related]
27. MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.
Rubinstein DB; Karmely M; Ziv R; Benhar I; Leitner O; Baron S; Katz BZ; Wreschner DH
Cancer Res; 2006 Dec; 66(23):11247-53. PubMed ID: 17145869
[TBL] [Abstract][Full Text] [Related]
28. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies.
Spencer DI; Price MR; Tendler SJ; De Matteis CI; Stadie T; Hanisch FG
Cancer Lett; 1996 Feb; 100(1-2):11-5. PubMed ID: 8620429
[TBL] [Abstract][Full Text] [Related]
29. A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.
Matsushita T; Takada W; Igarashi K; Naruchi K; Miyoshi R; Garcia-Martin F; Amano M; Hinou H; Nishimura S
Biochim Biophys Acta; 2014 Mar; 1840(3):1105-16. PubMed ID: 24246952
[TBL] [Abstract][Full Text] [Related]
30. Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop.
Berger P; Paus E; Hemken PM; Sturgeon C; Stewart WW; Skinner JP; Harwick LC; Saldana SC; Ramsay CS; Rupprecht KR; Olsen KH; Bidart JM; Stenman UH;
Tumour Biol; 2013 Dec; 34(6):4033-57. PubMed ID: 24068570
[TBL] [Abstract][Full Text] [Related]
31. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
[TBL] [Abstract][Full Text] [Related]
32. Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumor cells.
Persson J; Bäckström M; Johansson H; Jirström K; Hansson GC; Ohlin M
Tumour Biol; 2009; 30(4):221-31. PubMed ID: 19776674
[TBL] [Abstract][Full Text] [Related]
33. Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21.
Adluri S; Gilewski T; Zhang S; Ramnath V; Ragupathi G; Livingston P
Br J Cancer; 1999 Apr; 79(11-12):1806-12. PubMed ID: 10206297
[TBL] [Abstract][Full Text] [Related]
34. Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the epithelial mucin (MUC1) on tissue sections of adenolymphomas of the parotid (Warthin's tumours): role of epitope masking by glycans.
Cao Y; Karsten U
Histochem Cell Biol; 2001 Apr; 115(4):349-56. PubMed ID: 11405064
[TBL] [Abstract][Full Text] [Related]
35. The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat.
Takeuchi H; Kato K; Denda-Nagai K; Hanisch FG; Clausen H; Irimura T
J Immunol Methods; 2002 Dec; 270(2):199-209. PubMed ID: 12379325
[TBL] [Abstract][Full Text] [Related]
36. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
[TBL] [Abstract][Full Text] [Related]
37. Fast epitope mapping for the anti-MUC1 monoclonal antibody by combining a one-bead-one-glycopeptide library and a microarray platform.
Garcia-Martin F; Matsushita T; Hinou H; Nishimura S
Chemistry; 2014 Nov; 20(48):15891-902. PubMed ID: 25303614
[TBL] [Abstract][Full Text] [Related]
38. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
[TBL] [Abstract][Full Text] [Related]
39. Mouse mucin 1 (MUC1) defined by monoclonal antibodies.
Xing PX; Lees C; Lodding J; Prenzoska J; Poulos G; Sandrin M; Gendler S; McKenzie IF
Int J Cancer; 1998 Jun; 76(6):875-83. PubMed ID: 9626356
[TBL] [Abstract][Full Text] [Related]
40. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.
Zhou D; Xu L; Huang W; Tonn T
Molecules; 2018 May; 23(6):. PubMed ID: 29857542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
